期刊文献+

急性髓系白血病与急性淋巴系白血病的蛋白质组比较研究 被引量:2

Comparison of Proteomics between Acute Myeloid Leukemia and Acute Lymphoid Leukemia
下载PDF
导出
摘要 本研究通过对急性髓系白血病(AML)与急性淋巴系白血病(ALL)细胞比较蛋白质组分析,寻找亚型特异性的蛋白质表达谱。应用双向电泳分别分离AML不同亚型(M1、M2、M3)、ALL患者骨髓白血病细胞蛋白质,利用PDQuest 7.4软件分析双向电泳图谱差异蛋白质点,基质辅助的激光解析飞行时间质谱和生物信息学鉴定差异蛋白质。结果显示:经过电泳图谱分析得到21个差异蛋白质点,质谱鉴定提示15种蛋白有统计学意义。在AML中高表达的蛋白质包括髓过氧化物酶(MPO)、硫氧还蛋白依赖的过氧化物还原酶(PRDX3),钙网蛋白(CALR)、烯酰辅酶A水合酶ECH1等7种,在ALL中高表达的蛋白质包括ARHGDIB、肌动蛋白抑制蛋白1(PFN1)、肌动蛋白(ACTG1)等8种。结论:AML与ALL细胞存在差异蛋白质表达谱,这将有助于发现早期诊断的分子标志物及特异性治疗靶标。 The aim of this study was to explore the distinct protein profiles of different subtype of acute myeloid leukemia(AML),including M1,M2,M3 and acute lymphoid leukemia(ALL) by differential proteomic expression analysis.The proteins of bone marrow leukemia cells from AML and ALL patients were separated by two-dimensional electrophoresis(2-DE).2-DE patterns were analyzed by PDQuest 7.4 software and the differentially expressed proteins were identified by matrix-assisted laser desorption ionization-time of flight mass spectromety(MALDI-TOF-MS) and bioinformatics.The results indicated that 21 differentially expressed proteins were found by 2-DE and 15 were identified by MS to be significantly differentially expressed.In AML,seven proteins were highly expressed such as MPO,PRDX3,CALR and ECH1 and so on,and eight proteins were highly expressed in ALL,including ARHGDIB,PFN1 and ACTG1 and so on.It is concluded that the distinct protein profiles between AML and ALL have been proved.It may be helpful for the identification of new targets for specific treatment approaches and the molecular markers for the early diagnosis of leukemia.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第6期1353-1356,共4页 Journal of Experimental Hematology
基金 国家重点基础研究发展计划973项目(编号2006CB504201) 国家重点基础研究规划项目973计划项目(编号2004CB720100) 生物化学与分子生物学广东省重点学科资助
关键词 急性髓系白血病 急性淋巴系白血病 蛋白质组 acute myeloid leukemia acute lymphoid leukemia proteome
  • 相关文献

参考文献8

  • 1肖平,曾耀英,聂燕芳,林蔚,吴晓萍.骨髓白血病细胞蛋白质组双向电泳技术的建立与优化[J].中国实验血液学杂志,2008,16(3):497-500. 被引量:6
  • 2Davey FR,Erber WN,Gatter KC,et al.Immunophenotyping ofacute myeloid leukemia by immunoalkaline phosphatase(APAAP)labeling with a panel of antibodies.Am J Hematol,1987;26(2):157-166.
  • 3Ozgen U,Savasan S,Stout M,et al.Further elucidation ofmechanism of resistance to vincristine in myeloid cells:role ofhypochlorous acid in degradation of vincristine by myelo-peroxidase.Leukemia,2000;14(1):47-51.
  • 4Hong SH,Misek DE,Wang H,et al.An autoantibody-mediatedimmune response to calreticulin isoforms in pancreatic cancer.Cancer Res,2004;64(15):5504-5510.
  • 5Jin BF,He K,Wang HX,et al.proteomic analysis of ubiquitin-proteasome effcts:insight into the function of eukaryotic initiationfactor 5A.Oncogene,2003;22(31):4819-4830.
  • 6Fritz G,Just I,Kaina B.Rho-GTPases are over-expressed inhuman tumors.Int J Cancer,1999;81(5):682-687.
  • 7Cui JW,Wang J,He K,et al.Proteomic analysis of human acuteleukemia cells:insight into their classification.Clin Cancer Res,2004;10(20):6887-6896.
  • 8Posey SC,Bierer BE.Actin stabilization by Jasplakinolideenhances apoptosis induced by cytokine deprivation.J.Biol.Chem,1999;274(7):4259-4265.

二级参考文献10

  • 1段春燕,郑小莉,王松,景莉,何涛.急性淋巴细胞白血病白细胞蛋白质双向电泳技术的建立[J].现代医院,2006,6(2):58-60. 被引量:1
  • 2Hegedus CM, Gunn L, Skibola CF,et al. Proteomic analysis of childhood leukemia. Leukemia, 2005 ; 19 : 1713 - 1718.
  • 3Cui JW, Li WH, Wang J, et al. Proteomics-based identification of human acute leukemia antigens that induce humeral immune response. Mol Cell Proteomics, 2005 ;4:1718 -1724.
  • 4Hanash SM, Madoz-Gurpide J, Misek DE. Identification of novel targets for cancer therapy using expression proteomics. Leukemia, 2002 ; 16:478 - 485.
  • 5Carroll WL, Bhojwani D, Min D J, et al. Pediatric acute lymphoblastic leukemia. Hematology, Am Soc Hematol Educ Program, 2003:102 -131.
  • 6Voss T,Ahom H, Haberl P,et al. Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia. Int J Cancer, 2001 ;91:180 -186.
  • 7Zhu H, Pan S, Gu S,et al. Amino acid residue specific stable isotope labeling for quantitative proteomics. Rapid Commun Mass Spectrom, 2002 ; 16:2115 - 2123.
  • 8Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem,1976; 72:248 -254.
  • 9Neuhoff V, Arold N, Taube D ,et al. Improved staining of proteins in polyacrylamide gels including isoclectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G- 250 and R-250. Electrophoresis, 1988 ;9:255 -262.
  • 10郭尧君.SDS电泳技术的实验考虑及最新进展[J].生物化学与生物物理进展,1991,18(1):32-37. 被引量:137

共引文献5

同被引文献23

  • 1荆涛,荆友科,董胜国.蛋白质组学研究进展及在泌尿系肿瘤研究中的应用[J].肿瘤研究与临床,2006,18(5):348-351. 被引量:4
  • 2Kocevar N,Hudler P, Komel R. The progress of proteomic approachesin searching for cancer biomarkers. N Biotechnol, 2013, 30: 319-326.
  • 3Deutsch EW, Lam H, Aebersold R. Data analysis and bioinformaticstools for tandem mass spectrometry in proteomics. Physiol Genomics,2008,33: 18-25.
  • 4Mohamedali A, Guinn BA, Sahu S, et al. Serum profiling revealsdistinctive proteomic markers in chronic myeloid leukaemia patients.Br J Haematol, 2009, 144: 263-265.
  • 5Ge F,Bi LJ, Tao SC, et al. Proteomic analysis of multiple myeloma:current status and future perspectives. Proteomics Clin Appl, 2011,5:30-37.
  • 6Xiong Q, Zhong Q, Zhang J, et al. Identification of novel miR-21 targetproteins in multiple myeloma cells hy quantitative proteomics. JProteome Res, 2012, 11: 2078-2090.
  • 7Ge F, Zhang L, Tao SC, et al. Quantitative proteomic analysis of tumorreversion in multiple myeloma cells. J Proteome Res, 2011, 10: 845-855.
  • 8Russo D, Bisca A, Celano M, et al. Proteomic analysis of humanthyroid cell lines reveals reduced nuclear localization of Mn-SOD inpoorly differentiated thyroid cancer cells. J Endocrinol Invest, 2005,28: 137-144.
  • 9Ban Y, Yamamoto G, Takada M, et al. Proteomic profiling of thyroidpapillary carcinoma. J Thyroid Res, 2012, 2012: 815079.
  • 10Tan F, Jiang Y, Sun N, et al. Identification of isocitrate dehydrogenase1 as a potential diagnostic and prognostic biomarker for non-small celllung cancer by proteomic analysis. Mol Cell Proteomics, 2012,11:Mill 008821.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部